HUSSMAN STRATEGIC ADVISORS, INC. - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 372 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.2%.

Quarter-by-quarter ownership
HUSSMAN STRATEGIC ADVISORS, INC. ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2021$287,000
-11.4%
7,2000.0%0.06%
-11.9%
Q1 2021$324,000
-78.0%
7,200
-71.2%
0.07%
-82.2%
Q2 2020$1,474,000
+24.7%
25,0000.0%0.38%
+17.9%
Q1 2020$1,182,00025,0000.32%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
BB BIOTECH AG 6,529,838$404,393,00011.39%
DOWLING & YAHNKE LLC 676,379$41,888,0005.27%
Opus Point Partners Management, LLC 102,459$6,345,0004.19%
WILLIAM HARRIS INVESTORS INC 230,443$14,271,0003.43%
PINNACLE ASSOCIATES LTD 1,690,263$104,678,0002.20%
MESSNER & SMITH THEME VALUE INVESTMENT MANAGEMENT LTD /CA/ 21,298$1,319,0002.11%
Sonora Investment Management, LLC 126,763$7,850,0002.04%
Virtus ETF Advisers LLC 10,447$647,0001.78%
Apex Capital Management 1,020,096$63,175,0001.41%
PERKINS CAPITAL MANAGEMENT INC 19,900$1,232,0001.32%
View complete list of IONIS PHARMACEUTICALS INC shareholders